Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial

PURPOSE: Fatigue is a distressing symptom occurring in more than 60% of patients with cancer. The CNS stimulants modafinil and methylphenidate are recommended for the treatment of cancer-related fatigue, despite a limited evidence base. We aimed to evaluate the efficacy and tolerability of modafinil...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Spathis, A, Fife, K, Blackhall, F, Dutton, S, Bahadori, R, Wharton, R, O'Brien, M, Stone, P, Benepal, T, Bates, N, Wee, B
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: American Society of Clinical Oncology 2014